How frequently may an adult take rizatriptan (Maxalt) on an as‑needed basis for migraine attacks?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How Often Can Someone Take PRN Rizatriptan for Migraine

Rizatriptan can be taken every 2 hours as needed for migraine recurrence, with a maximum of 30 mg (three 10-mg doses) in any 24-hour period. 1

Standard Dosing Frequency

  • The FDA-approved dosing allows a second dose 2 hours after the first dose if the migraine returns, with the critical limitation being no more than 30 mg total in 24 hours 1
  • For patients on propranolol, use only 5-mg doses with a maximum of 15 mg (three doses) in 24 hours 1
  • The American Academy of Family Physicians supports this every-2-hour dosing interval when headache recurs 2

Maximum Monthly Use to Prevent Medication Overuse Headache

A critical pitfall is overuse leading to medication overuse headache—limit rizatriptan to no more than 10 days per month. 2 This threshold is lower than for NSAIDs and must be monitored carefully to avoid transforming episodic migraine into chronic daily headache.

Optimal Treatment Strategy

  • Take rizatriptan early when headache is still mild for maximum effectiveness—do not wait until pain becomes severe 3
  • Trial rizatriptan for 2-3 separate migraine episodes before abandoning it, as response can vary between attacks 4, 2, 3
  • If one triptan fails after adequate trial, switch to a different triptan (such as sumatriptan, eletriptan, or naratriptan), as individual patients respond differently to different triptans 4, 2

When Single-Dose Rizatriptan Is Insufficient

If rizatriptan alone provides inadequate relief, add an NSAID (naproxen, ibuprofen, or diclofenac) rather than increasing triptan frequency. 3 Combination therapy with triptan plus NSAID is more effective than either agent alone or increasing the triptan dose.

Formulation Selection Based on Symptoms

  • Use orally disintegrating tablets (Maxalt MLT) when nausea or vomiting are present, as they do not require water and may be better tolerated 4, 2, 3
  • Standard tablets are appropriate when gastrointestinal symptoms are minimal 1

Contraindications That Preclude Use

Rizatriptan is absolutely contraindicated in patients with:

  • Coronary artery disease, vasospastic conditions, or uncontrolled hypertension 4, 3
  • Hemiplegic or basilar migraine 2, 3
  • Concurrent use with ergotamine derivatives or within 24 hours of another triptan 4, 2, 3
  • Current MAOI use or within 2 weeks of discontinuation 3
  • Pregnancy 2, 3

Pediatric Dosing (Ages 6-17 Years)

  • For children weighing <40 kg (88 lb): 5 mg single dose 1
  • For children weighing ≥40 kg (88 lb): 10 mg single dose 1
  • The safety of multiple doses within 24 hours has not been established in pediatric patients 1

Common Adverse Effects to Counsel Patients About

  • Chest pressure, heaviness, or throat tightness occur commonly but are typically transient (2-3 hours) and mild to moderate 2, 5
  • Dizziness, somnolence, and fatigue are dose-related 6

References

Guideline

Rizatriptan Dosage and Administration for Acute Migraine Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Acute Migraine Treatment with Triptans

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Rizatriptan in the treatment of migraine.

Clinical therapeutics, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.